ストックスクリーナーアプリを入手
1.785
2.46%
-0.045
前日終値:
$1.83
開ける：
$1.84
24時間の取引高:
215.47K
Relative Volume:
0.23
時価総額：
$47.45M
収益：
$155.00K
当期純損益:
$-30.01M
株価収益率:
-1.0689
EPS:
-1.67
ネットキャッシュフロー:
$-11.98M
1週間 パフォーマンス:
-2.99%
1か月 パフォーマンス:
-14.18%
6か月 パフォーマンス:
-77.00%
1年 パフォーマンス:
-70.45%
1日の値動き範囲:
$1.7517
$1.88
1週間の範囲:
$1.73
$1.9262
52週間の値動き範囲:
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
名前
Inmune Bio Inc
セクター
電話
(858) 964-3720
住所
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.785 | 48.65M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.71 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.33 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.86 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-01 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-01 | ダウングレード | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-21 | 開始されました | Alliance Global Partners | Buy |
| 2024-09-27 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Scotiabank | Sector Outperform |
| 2023-06-01 | 開始されました | Robert W. Baird | Outperform |
| 2022-05-24 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
| 2021-04-21 | 開始されました | B. Riley Securities | Buy |
| 2021-01-22 | 繰り返されました | Maxim Group | Buy |
| 2020-09-01 | 開始されました | BTIG Research | Buy |
| 2020-07-15 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Inmune Bio Inc (INMB) 最新ニュース
Is INmune Bio Inc. a candidate for recovery playTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Sentiment analysis tools applied to INmune Bio Inc.Wall Street Watch & Long-Term Capital Growth Strategies - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Heatmap analysis for INmune Bio Inc. and competitorsMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Does INmune Bio Inc. stock trade at a discount to peersMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Short interest data insights for INmune Bio Inc.Weekly Loss Report & High Conviction Trade Alerts - newser.com
What makes INmune Bio Inc. stock attractive to growth fundsQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Earnings visualization tools for INmune Bio Inc.Rate Cut & Safe Entry Point Identification - newser.com
Published on: 2025-11-02 21:20:18 - newser.com
Published on: 2025-11-02 20:37:16 - newser.com
Inmune Bio Reports Q3 2025 Financial Results - MSN
How INmune Bio Inc. stock reacts to Fed rate cutsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Statistical indicators supporting INmune Bio Inc.’s strengthMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript - Insider Monkey
Will INmune Bio Inc. stock outperform tech sector in 2025Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
Inmune Bio to Host Q3 Results Conference Call - MSN
What analysts say about INmune Bio Inc stockMarket Liquidity Analysis & High Return Trading Ideas - earlytimes.in
How INmune Bio Inc. stock benefits from global expansionJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Candlestick signals on INmune Bio Inc. stock todayWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Sector ETF performance correlation with INmune Bio Inc.July 2025 Trends & AI Driven Price Forecasts - newser.com
Can volume confirm reversal in INmune Bio Inc.July 2025 Volume & Fast Moving Market Watchlists - newser.com
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips - Investing.com Australia
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa
Is INmune Bio Inc. stock overvalued by current metricsRisk Management & Daily Growth Stock Tips - newser.com
Inmune Bio outlines 2026 regulatory milestones and cash runway through Q4 2026 - MSN
Is it time to cut losses on INmune Bio Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Transcript : INmune Bio, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulatory Progress and Financial ... - Yahoo Finance
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulato - GuruFocus
INmune Bio Shrinks Losses While Analysts See Upside Ahead - Finimize
INMB Maintains Strong Cash Position with $27.7 Million on Hand - GuruFocus
INmune Bio Q3 net loss narrows to $6.5 mln, names new CEO - MarketScreener
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
INmune Bio Inc. (INMB) Q3 FY2025 earnings call transcript - Yahoo Finance
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update - The Manila Times
INmune Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
INMB posts Q3 loss and $16,514,000 impairment amid XPro setback - Stock Titan
Inmune Bio Inc (INMB) 財務データ
収益
当期純利益
現金流量
EPS
0.43%
0.05%
大文字化:
|
ボリューム (24 時間):